Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The BOOST Study
NCT06834594Phase 4Recruiting
- Sponsor
- Children's Mercy Kansas City
- Start
- Jul 2025
- Primary completion
- Jul 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of progesterone in Turner syndrome (TS) and primary ovarian insufficiency (POI) (2 arms), sponsored by Children's Mercy Kansas City. Primary endpoint: Pictorial Bleeding Assessment Chart at 90 days. Started Jul 2025; status: recruiting.
02
Drugs
progesterone
03
Conditions
Turner syndrome (TS)primary ovarian insufficiency (POI)
Beyond the preview
Go deeper on NCT06834594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06834594.